PANAVIR (rectal suppositories 200 mcg 5 pcs) - antiviral and immunomodulatory agent

PANAVIR (rectal suppositories 200 mcg 5 pcs). The active substance is the polysaccharides of the shoots of potato (Solanum tuberosum). Panavir® - purified extract of the shoots of the plant Solanum tuberosum; the main active ingredient is a hexose glycoside, consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids. It increases the body's nonspecific resistance to various infections and promotes the induction of alpha and gamma interferons by blood leukocytes.

Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies on laboratory animals, no negative effects on reproductive function and fetal development have been established. It has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation and in the test of pseudo-allergic inflammatory response to concanavalin A.

An analgesic effect was shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation. Has an antipyretic effect. Neuroprotective properties are shown on the model of parkinsonian syndrome caused by the systemic administration of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

It has the ability to improve the function of the retina and optic nerve. It has wound-healing properties in conditions of a model of gastric ulcer.

Direction:

antiviral and immunomodulatory preparation.

Ingredients:

Active substance - Panavir® (potato shoots total polysaccharides) - 200 mcg

Excipients: confectionery fat or solid fat - 1.0198 g, paraffin - 0.0900 g, emulsifier T-2 - 0.0900 g.

The mass of the suppository is 1.2 g.

Indications:

• Herpesvirus infections of various localization (including recurrent genital herpes, herpes zoster and ophthalmic herpes).
• Secondary immunodeficiency states on the background of infectious diseases.
• Cytomegalovirus infection, including in patients with recurrent miscarriage.
• It is used in women with chronic viral infection and interferon deficiency in the preparation for pregnancy.
• Chronic cytomegalovirus infection in the acute stage in pregnant women in the II and III trimester as part of complex therapy.
• Papillomavirus infection (anogenital warts) as part of complex therapy.
• Peptic ulcer of the stomach and duodenum in patients with long-term scarring ulcers and symptomatic ulcers of the gastroduodenal zone as part of complex therapy.
• Tick-borne encephalitis in order to reduce the viral load and relieve neurological symptoms (anisoreflexia, decreased reflexes, painful exit points of the cranial nerves, nystagmus) as part of complex therapy.
• Rheumatoid arthritis combined with herpesvirus infection in immunocompromised patients (to enhance the analgesic and anti-inflammatory effect of the main therapy), as part of complex therapy.
• SARS and influenza as part of complex therapy.
• Panavir® is used in the complex therapy of chronic bacterial prostatitis.

Dosage:

Rectally

For the treatment of herpesvirus infections and tick-borne encephalitis, 1 suppository is used twice with an interval of 48 or 24 hours. If necessary, the course of treatment can be repeated after 1 month.

For the treatment of cytomegalovirus and papillomavirus infections, 1 suppository is used three times during the first week with an interval of 48 hours and twice during the second week with an interval of 72 hours.

For the treatment of acute respiratory viral infections and influenza, 1 suppository is used with an interval of 24 hours for 5 days.

Contraindications for use:

Individual intolerance. Panavir® should not be used in patients with allergies to the constituent components of the preparation: glucose, mannose, rhamnose, arabinose, xylose.

lactation period.

Children's age up to 12 years.

Description:

Suppositories from white to white with a yellowish tint, cone-shaped or cylindrical in shape, yellowish-gray blotches are allowed, odorless.

Release form:

Suppositories rectal 200 mcg.

5 suppositories in a blister pack, 1 blister pack along with instructions for use in a cardboard pack.

Storage conditions:

In a dry, dark place, at a temperature of 2 to 8 °C.

Best before date:

3 years. Do not use after the expiry date stated on the package

Guaranteed authenticity and quality:

100% original product from ALTPHARM LLC (Russian Federation)

Development:

LLC National Research Company is a rapidly growing company whose activities are aimed at developing high-tech medical projects in the following areas:

• development of innovative preparations and medical technologies for various medical fields;
• development and implementation of antiviral preparations and antiseptics;
• production and synthesis of substances;
• study of biologically active substances isolated from rapidly dividing plant cells;
• organization of preclinical and clinical studies;
• registration of medicines and dietary supplements in the Ministry of Health and Social Development of the Russian Federation;
• organization of production and promotion of new medicines and dietary supplements.

The management of scientific research work is carried out by Academician of the Russian Academy of Medical Sciences, Professor V.I. Sergienko. – Director of the Research Institute of Physical and Chemical Medicine of the Ministry of Health and Social Development of the Russian Federation.

Production:

ALTPHARM LLC (Russian Federation)